Allurion Technologies Inc. (ALUR)
OTCMKTS
· Delayed Price · Currency is USD
0.740
-0.060 (-7.48%)
At close: Apr 28, 2026
Allurion Technologies Employees
As of December 31, 2025, Allurion Technologies had 41 total employees, including 38 full-time and 3 part-time employees. The number of employees decreased by 96 or -70.07% compared to the previous year.
Employees
41
Change (1Y)
-96
Growth (1Y)
-70.07%
Revenue / Employee
$380,750
Profits / Employee
-$718,875
Market Cap
11.11M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 41 | -96 | -70.07% |
| Dec 31, 2024 | 137 | -115 | -45.63% |
| Dec 31, 2023 | 252 | -4 | -1.56% |
| Dec 31, 2022 | 256 | 29 | 12.78% |
| Dec 31, 2021 | 227 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ALR Technologies SG | 7 |
| QHSLab | 12 |
| REMSleep Holdings | 2 |
| Guided Therapeutics | 4 |
| Ludwig Enterprises | 5 |
| Biotricity | 46 |
| Odyssey Health | 2 |
Allurion Technologies News
- 8 days ago - Allurion Treats First Commercial Patients in the United States, Marking Major Milestone - Business Wire
- 6 weeks ago - Allurion Advances Plan to Regain Listing Compliance - Business Wire
- 6 weeks ago - Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy - Business Wire
- 7 weeks ago - NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - Business Wire
- 2 months ago - Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE - Business Wire
- 2 months ago - Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds - Business Wire
- 2 months ago - Allurion Receives U.S. FDA Approval - Business Wire
- 3 months ago - Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices - Business Wire